Terms: = Head and neck cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Clinical Outcome
3 results:
1. Metastatic lymph node CHIP expression is a potential prognostic marker for resected esophageal squamous cell carcinoma patients.
Wen J; Luo KJ; Hu Y; Yang H; Fu JH
Ann Surg Oncol; 2013 May; 20(5):1668-75. PubMed ID: 23429937
[TBL] [Abstract] [Full Text] [Related]
2. Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas.
Slotta-Huspenina J; Berg D; Bauer K; Wolff C; Malinowsky K; Bauer L; Drecoll E; Bettstetter M; Feith M; Walch A; Höfler H; Becker KF; Langer R
PLoS One; 2012; 7(7):e41420. PubMed ID: 22911792
[TBL] [Abstract] [Full Text] [Related]
3. P53-dependent radiosensitizing effects of hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin on human oral squamous cell carcinoma cell lines.
Shintani S; Zhang T; Aslam A; Sebastian K; Yoshimura T; Hamakawa H
Int J Oncol; 2006 Nov; 29(5):1111-7. PubMed ID: 17016641
[TBL] [Abstract] [Full Text] [Related]
